Rituxem 100 mg/10ml Injection Substitute
Composition:
RITUXIMAB-100MG
Uses:
Rituxem 100 mg/10ml Injection is used in the treatment of Non-Hodgkin's disease, rheumatoid arthritis, chronic lymphocytic leukaemia, granulomatosis and pemphigus vulgaris. The detailed uses of Rituxem 100 mg/10ml Injection are as follows:<br/>• Non-Hodgkin’s Lymphoma (NHL): Rituxem 100 mg/10ml Injection is used to treat Non-Hodgkin’s Lymphoma alone or with chemotherapy.<br/>• Chronic Lymphocytic Leukemia (CLL): Rituxem 100 mg/10ml Injection is used in the treatment of Chronic Lymphocytic Leukemia (CLL) and B-cell Acute Lymphoblastic Leukemia (B-ALL.<br/>• Rheumatoid Arthritis (RA): Rituxem 100 mg/10ml Injection is used in the treatment of rheumatoid arthritis.<br/>• Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA): Rituxem 100 mg/10ml Injection helps to treat Granulomatosis with Polyangiitis and Microscopic Polyangiitis.<br/>• Pemphigus Vulgaris: Rituxem 100 mg/10ml Injection is used to treat pemphigus vulgaris for moderate to severe cases.<br/>
Medicinal Benefits:
Rituxem 100 mg/10ml Injection contains Rituximab, which belongs to the class of monoclonal antibodies. It works by inhibiting the DNA and RNA transcription that is essential for cancer cell growth. This helps prevent the growth and further spread of cancerous or non-cancerous cells. On the other hand, Rituxem 100 mg/10ml Injection works by interfering with the immune system process that causes inflammation in the joint tissues. Thus, it reduces pain and inflammation and prevents joint damage and disease progression over time.
Rituxem 100 mg/10ml Injection is used to treat Non-Hodgkin’s disease, rheumatoid arthritis, chronic lymphocytic leukaemia, granulomatosis and pemphigus vulgaris.
Rituxem 100 mg/10ml Injection contains Rituximab, which works by inhibiting the DNA and RNA transcription that is essential for cancer cell growth.
Rituxem 100 mg/10ml Injection may cause bowel obstruction and perforation, reactivation of Hepatitis B infection, Cardiac arrhythmias, tumour lysis syndrome, and angina in some patients. Hence, inform your oncologist about your complete medical history, including current medication, to rule out any side effects/interactions.
Rituxem 100 mg/10ml Injection contains the active substance rituximab. This is a type of protein called a monoclonal antibody.
The common side effects of Rituxem 100 mg/10ml Injection are pale skin, painful urination, night sweats, flushing, back pain, nausea, vomiting, diarrhoea, stomach pain, mouth sores, peeling of skin, injection site reactions and pain at the site of injection. If any of these side effects persist or worsen, please consult your doctor.